Doubts about BioWatch were aired in Congress today, with a House committee chair criticizing plans and a top federal disease expert expressing concerns.
Resources & Literature
Recent Literature
Enki DG, Noufaily A, Garthwaite PH, et al.Automated biosurveillance data from England and Wales, 1991-2011. Emerg Infect Dis 2013 Jan;19(1):35-42
GAO (US Government Accountability Office).Efforts to address the medical needs of children in a chemical, biological, radiological, or nuclear incident. GAO-13-438. Apr 30, 2013
GAO (US Government Accountability Office).High-containment laboratories: assessment of the nation's need is missing. GAO-13-466R. Posted Mar 25, 2013 (but dated Feb 25)
Lumpkin JR, Miller YK, Inglesby T, et al.The importance of establishing a national health security preparedness index. (Commentary) Biosecur Bioterror 2013 Mar 28;11(1):81-7
Madrid PB, Chopra S, Manger ID, et al.A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One 2013 Apr 5;8(4):e60579
Merens A, Cavallo JD, Thibault F, et al.Assessment of the bio-preparedness and of the training of the French hospital laboratories in the event of biological threat. Euro Surveill 2012 Nov 8;17(45):pii=20312
National Research Council. Technologies to enable autonomous detection for BioWatch: ensuring timely and accurate information for public health officials. Sep 4, 2013
